Lupin Pharmaceuticals Inc. Recall: Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591
Lupin Pharmaceuticals Inc. Recall: Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591 is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Lupin Pharmaceuticals Inc.; Product: Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count
| Recalling firm | Lupin Pharmaceuticals Inc. |
|---|---|
| Product | Ramipril Capsules USP 10 mg, a) 90 count (NDC 68180-591-09), b) 100 count NDC 68180-591-01), and c) 500 count (NDC 68180-591-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India |
| Reason for recall | CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide. |
| Recall initiated | 20241023 |
| Recall number | D-0054-2025 |
| Category | drug |
| State | MD |
| Country | United States |
$29/mo
Try RecallGuard →